Blog

Discover our latest articles and blogs

Testosterone Cypionate Half-Life: How Long It Lasts
November 17, 2026

Testosterone Cypionate Half-Life: How Long It Lasts

Testosterone cypionate has a label half-life of about eight days. See what that means for peak levels, dosing intervals and when to time your blood draw.

GLP-1 and Birth Control: What Changes and What Doesn't
November 16, 2026

GLP-1 and Birth Control: What Changes and What Doesn't

Do GLP-1 drugs weaken birth control? Tirzepatide can lower pill absorption, semaglutide mostly doesn't. Learn who needs backup and what to ask your clinician.

GLP-1 Medicines and Cholesterol: What the Evidence Shows
November 15, 2026

GLP-1 Medicines and Cholesterol: What the Evidence Shows

How GLP-1 medicines such as semaglutide and tirzepatide affect LDL, HDL and triglycerides, what happens after stopping, and what to ask your clinician.

GLP-1 Maintenance Plan: What to Ask Before and After Goal Weight
November 14, 2026

GLP-1 Maintenance Plan: What to Ask Before and After Goal Weight

What a GLP-1 maintenance plan involves after goal weight: dose decisions, spacing, regain data, lifestyle targets and questions to bring to your clinician.

Kisspeptin Therapy: What the Evidence and FDA Status Show
November 13, 2026

Kisspeptin Therapy: What the Evidence and FDA Status Show

Kisspeptin therapy explained: how it affects LH and testosterone, what studies tested, how it compares with hCG, and its US regulatory status.

PT-141 Dosing: What the FDA Label Says About Bremelanotide
November 12, 2026

PT-141 Dosing: What the FDA Label Says About Bremelanotide

PT-141 (bremelanotide) dosing as the FDA label states it: dose, timing, monthly limits, side effects, cost, and how to prepare for a clinician visit.

Testosterone and Mood: What the Research Shows
November 11, 2026

Testosterone and Mood: What the Research Shows

Can testosterone therapy improve mood or depression? See what major trials show, who may benefit, the limits, and how to prepare questions for a clinician.

TRT and Prostate Health: What the Evidence Shows
November 10, 2026

TRT and Prostate Health: What the Evidence Shows

Does testosterone therapy affect the prostate? See what FDA, VA and trial data say about cancer, BPH, PSA monitoring, blood pressure and heart risk.

Peptides With GLP-1: What Is Approved, What Isn't
November 9, 2026

Peptides With GLP-1: What Is Approved, What Isn't

GLP-1 medicines are peptides, but 'peptides with GLP-1' often means unapproved add-ons. See what the evidence says and what to ask a clinician.